首页> 外国专利> AGENT FOR PREVENTING AND TREATING AIDS OR VIRAL DISEASE SUCH AS CHRONIC HEPATITIS, B TYPE HEPATITIS OR C TYPE HETATITIS

AGENT FOR PREVENTING AND TREATING AIDS OR VIRAL DISEASE SUCH AS CHRONIC HEPATITIS, B TYPE HEPATITIS OR C TYPE HETATITIS

机译:预防和治疗艾滋病或病毒性疾病(例如慢性乙型肝炎,B型肝炎或C型肝炎)的代理商

摘要

PURPOSE:To obtain the subject preventing and treating agent more profitable and effective than interferon and functioning without causing side effects. CONSTITUTION:The agent for preventing and treating AIDS and viral diseases such as chronic hepatitis, B type hepatitis or C type hepatitis contains a neutral protease selected from a neutral protease produced from a Streptomyces microbe, a serratia peptidase produced from a Serratia microbe, and thermolysin produced from a Bacillus microbe as an active ingredient. The neutral protease includes trypsin, alpha-chymotrypsin, bromelain, papain, and sephaprose, and has extremely strong antiinflammatory action, antiviral action, anti-AIDS action, immune-increasing action and steroid-like action. The preventing and treating agent is administered at a dose of 1-5000mg/day for an adult on oral administration.
机译:目的:获得比干扰素更有益和有效的主题预防和治疗药物,并且在不引起副作用的情况下起作用。组成:用于预防和治疗艾滋病和病毒性疾病(例如慢性肝炎,B型肝炎或C型肝炎)的药物包含选自链霉菌微生物产生的中性蛋白酶,粘质沙雷氏菌微生物产生的粘质沙雷肽酶和嗜热菌蛋白酶的中性蛋白酶。由芽孢杆菌属微生物产生的活性成分。中性蛋白酶包括胰蛋白酶,α-胰凝乳蛋白酶,菠萝蛋白酶,木瓜蛋白酶和琼脂糖,具有极强的抗炎作用,抗病毒作用,抗艾滋​​病作用,免疫增强作用和类固醇作用。对于成年人,口服口服该预防和治疗剂的剂量为1-5000mg /天。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号